Wednesday, July 8, 2026

Patent intelligence · US

US 7473435

Bioactive compositions form Theacea plants and processes for their production and use

granted A61KA61K31/353A61K36/82A61K8/9789
Status granted
Linked drugs 3
Pipeline programs 6
Years to expiry 2
Applicant portfolio 42
Patent details — US 7473435
Jurisdiction
US
Status
granted
Grant date
Jan 6, 2009
Expiration
Jan 1, 2029
Claims
16
CPC classes
A61K, A61K31/353, A61K36/82, A61K8/9789
View on Google Patents ↗

Quick answer

US 7473435 (Bioactive compositions form Theacea plants and processes for their production and use) is held by INTEGRATED BOTANICAL TECHNOLOGIES, LLC. Status: granted. Granted Jan 6, 2009. Expires Jan 1, 2029 (2 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
16
CPC classes
A61K, A61K31/353, A61K36/82, A61K8/9789, A61P, A61P17/00

More from INTEGRATED BOTANICAL TECHNOLOGIES, LLC

Related pharmaceutical patents in our USPTO index.

  1. US 12076377

    Variant sulfatase enzymes with enhanced properties

    INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. · Expires Aug 29, 2044

    granted
  2. US 11421021

    Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptides

    INTEGRATED BIOTHERAPEUTIC VACCINES, INC. · Expires Aug 18, 2042

    granted
  3. US 11260120

    Immunogenic composition comprising a fusion peptide derived from superantigen toxoids

    INTEGRATED BIOTHERAPEUTIC VACCINES, INC. · Expires Feb 24, 2042

    granted
  4. US 11186626

    Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop

    INTEGRATED BIOTHERAPEUTICS, INC. · Expires Nov 25, 2041

    granted
  5. US 11154614

    Method for producing virus like particles

    INTEGRATED RESEARCH ASSOCIATES, LLC · Expires Oct 21, 2041

    granted
  6. US 11135280

    Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity

    INTEGRATED BIOTHERAPEUTICS, INC. · Expires Sep 30, 2041

    granted
  7. US 11028153

    Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins

    INTEGRATED BIOTHERAPEUTICS, INC. · Expires Jun 3, 2041

    granted
  8. US 10653800

    Oligonucleotide-based probes for detection of bacterial nucleases

    INTEGRATED DNA TECHNOLOGIES, INC. · Expires May 14, 2040

    granted

Frequently asked questions

What is US patent 7473435?

US 7473435 (Bioactive compositions form Theacea plants and processes for their production and use) is held by INTEGRATED BOTANICAL TECHNOLOGIES, LLC. Status: granted. Granted Jan 6, 2009. Expires Jan 1, 2029 (2 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 7473435?

INTEGRATED BOTANICAL TECHNOLOGIES, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 42 pharmaceutical patents for this assignee.

When does US 7473435 expire?

Our index shows an expiration date of Jan 1, 2029 (2 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.